{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:12:29Z","timestamp":1785892349590,"version":"3.56.0"},"reference-count":35,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2012,7,4]],"date-time":"2012-07-04T00:00:00Z","timestamp":1341360000000},"content-version":"vor","delay-in-days":6394,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[1995,1]]},"abstract":"<jats:p>1. The in vitro hepatic metabolism of lignocaine to monoethylglycinexylide (MEGX) is mediated by CYP3A4 and that of coumarin to 7\u2010hydroxycoumarin (7OHC) by CYP2A6. We investigated the usefulness of monitoring serum MEGX concentrations (after 1 mg kg\u20101 lignocaine i.v.) and urinary 7OHC excretion (after 5 mg coumarin p.o.) to reflect liver function in patients with liver (n = 36), kidney (n = 12) and epileptic (n = 12) disease and in control subjects (n = 20). The extent of liver disease was assessed using measurements of serum aminoterminal propeptide (PIIINP) and Child\u2010Pugh grades. 2. Serum concentrations of MEGX were decreased in severe (4.6 +\/\u2010 3.0 s.d. ng ml\u2010 1), moderate (19.1 +\/\u2010 11.6 s.d. ng ml\u20101) and mild (32.8 +\/\u2010 14.2 s.d ng ml\u20101) liver disease as compared with controls (53.4 +\/\u2010 15.8 s.d ng ml\u20101). The excretion of 7OHC over 2 h was decreased in severe (18.0 +\/\u2010 10.3 s.d % of dose) and moderate (34.2 +\/\u2010 15.6 s.d %), but not in mild (49.7 +\/\u2010 19.0 s.d %) liver disease as compared with that in controls (56.2 +\/\u2010 11.6%). 3. In epileptic patients the urinary recovery of 7OHC was increased (2 h value 69.5 +\/\u2010 13.2 s.d %) suggesting enzyme induction. In contrast, serum MEGX concentration were low (40.0 +\/\u2010 14.1 s.d ng ml\u20101), possibly due to competition for CYP3A4 between lignocaine and antiepileptic drugs. 4. In patients with kidney disease serum MEGX concentration (56.5 +\/\u2010 26.1 s.d ng ml\u20101) was similar to that in controls.(ABSTRACT TRUNCATED AT 250 WORDS)<\/jats:p>","DOI":"10.1111\/j.1365-2125.1995.tb04412.x","type":"journal-article","created":{"date-parts":[[2012,7,5]],"date-time":"2012-07-05T04:32:00Z","timestamp":1341462720000},"page":"71-76","source":"Crossref","is-referenced-by-count":55,"title":["CYP3A4 and CYP2A6 activities marked by the metabolism of lignocaine and coumarin in patients with liver and kidney diseases and epileptic patients."],"prefix":"10.1111","volume":"39","author":[{"given":"EA","family":"Sotaniemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Rautio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Backstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Arvela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Pelkonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,7,4]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"845","article-title":"Monoethylglycinexylidide formation kinetics: A novel approach to assessment of liver function","volume":"25","author":"Oellerich M.","year":"1987","journal-title":"J clin Chem clin Biochem"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1989.180"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(88)90070-6"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-199210000-00005"},{"issue":"1","key":"e_1_2_1_6_2","first-page":"24","article-title":"Coumarin 7\u2010hydroxylase: Characteristics and regulation in mouse and man","volume":"22","author":"Pelkonen O.","year":"1993","journal-title":"J Ir Coll Phys Surg"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1986.138"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00607680"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800600817"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830330105"},{"key":"e_1_2_1_11_2","unstructured":"ArvelaP. LeinonenA. RautioA. Salonp\u00e4\u00e4P. SotaniemiEA PelkonenO.Comparison of two methods to measure lidocaine metabolite as a liver function testSixth Southeast Asian\/Western Pacific Regional Meeting of Pharmacologists1991 p167."},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1080\/01483917908060085"},{"key":"e_1_2_1_13_2","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/clinchem\/34.4.715","article-title":"Rapid equilibrium radioimmunossay for the amino\u2010terminal propeptide for human type III procollagen","volume":"34","author":"Risteli J.","year":"1988","journal-title":"Clin Chem"},{"key":"e_1_2_1_14_2","first-page":"131","article-title":"Serum type III procollagen and basement membrane antigens in hepatitis B virus liver disease","volume":"3","author":"Sotaniemi EA","year":"1992","journal-title":"Eur J int Med"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(85)90013-0"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(70)80135-8"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.1979.tb00912.x"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197907053010104"},{"key":"e_1_2_1_19_2","first-page":"61","volume-title":"Connective tissue in health and disease","author":"Risteli L.","year":"1990"},{"key":"e_1_2_1_20_2","first-page":"501","article-title":"Macrophage\u2010dependent factor that stimulates the proliferation of fibroblasts in vitro","volume":"84","author":"Leibovich SJ","year":"1976","journal-title":"Am J Path"},{"key":"e_1_2_1_21_2","doi-asserted-by":"crossref","first-page":"942","DOI":"10.4049\/jimmunol.121.3.942","article-title":"Lymphocyte mediated activation of fibroblast proliferation and collagen production","volume":"121","author":"Wahl SM","year":"1978","journal-title":"J Immunol"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0676.1985.tb00228.x"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(05)80002-9"},{"key":"e_1_2_1_24_2","first-page":"61","article-title":"Effect of medroxyprogesterone acetate on liver collagen and drug metabolism in rats after chemical liver injury","volume":"42","author":"Saarni HU","year":"1983","journal-title":"Res Comm Chem Path Pharmac"},{"key":"e_1_2_1_25_2","first-page":"5","article-title":"Precursor lesions of cirrhosis","volume":"18","author":"Lieber CS.","year":"1983","journal-title":"Alcohol Alcoholism"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(63)80130-4"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.20.8.673"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.3109\/10408449209145319"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199304000-00001"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1993.25"},{"key":"e_1_2_1_31_2","first-page":"97","article-title":"Identification of a polymorphically expressed member of human cytochrome p\u2010450 III family","volume":"36","author":"Wrighton SA","year":"1989","journal-title":"Mol Pharmac"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj2630653"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj2810577"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00561021"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1989.tb03516.x"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1994.tb04307.x"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2125.1995.tb04412.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2125.1995.tb04412.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T21:30:52Z","timestamp":1698355852000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2125.1995.tb04412.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1995,1]]}},"alternative-id":["10.1111\/j.1365-2125.1995.tb04412.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2125.1995.tb04412.x","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,1]]}}}